Metropolis Healthcare launches Oncomet

Press Release

Oncomet - metropolis logos

Metropolis Healthcare launches Oncomet
Becomes the first to offer comprehensive reflex testing for conclusive diagnosis in Cancer in India

Mumbai November 11, 2014: Metropolis Healthcare Ltd, The Pathology Specialists, launched Oncomet, a specialized division in Oncology Diagnosis in order to make cancer testing affordable and accessible for the Indian population. Oncomet will offer more than 500 varieties of specialized test panels, spanning over screening, diagnostic, predictive, prognostic & theranostic role of laboratory in patient management.

Oncomet is designed to provide conclusive and cost effective cancer testing by correlating all techniques and technology with Morphology which refers to the histological classification of the cancer tissue. Cancer treatment has shifted in recent years to the use of biologic therapeutics that target genomic alterations in cancers, creating demand for more advanced and sensitive genomic testing to identify these alterations. Oncomet will provide diagnostically more significant information and correctly identify mutations present in smaller samples.

An additional initiative of Oncomet is to offer Reflex Testing, an important tool in providing timely, cost-effective and quality care to patients. Reflex Testing is a follow-up testing automatically initiated when certain test results are observed in the laboratory which can be used to clarify or elaborate on primary test results.

As a value addition, Oncomet’s scientific team will be in close contact with the consulting doctor to discuss laboratory findings in detail. The expert team will then take a call on reflex testing and discuss the results again with the consulting doctor to provide conclusive report. This will be done for every single report that presents a complication in diagnosis to remove any element of doubt and offer a report that will aid the doctor in disease management.

Oncomet also has a unique advantage of an esteemed organ – specific experts and consultation services. Organ specific histopathology consultation services are fast catching up in the western world and we are pleased and proud to be the first movers to offer this value addition to our customers. These experts will also build a bio-registry of oncology cases will serve as a reference point for the industry.

Speaking on the occasion Dr. Kirti Chadha, Onco Pathologist & Divisional Head - Oncology said “Oncomet is an initiative to provide affordable and accessible testing for cancer, with the pool of eminent experts & oncopathologists. Our commitment is to adhere to the highest level of quality in laboratory services and patient care”.

Metropolis’s Oncology Directory of Services is accredited by the College of American Pathologists (CAP) and adheres to American Society of Clinical Oncology (ASCO) WHO Grading & AJCC/TNM Staging for Standardized Oncology reporting. The tests span Anatomic pathology/Histology, Cytology/LBC, IHC, Hematology, Flow Cytometry, CISH, FISH & PCR. Designed to go well beyond regulatory compliance, the program helps laboratories achieve the highest standards of excellence to positively impact patient care.


At Metropolis, what we believe is what we say and what we say is what we do. Being empathetic to our customers and being committed to their needs is in our DNA. Metropolis has grown to harness a culture that is open, synergistic, progressive and scientific in nature.

We are the Pathology Specialists delivering over 15 million tests a year, catering to more than 10,000 Laboratories, Hospitals, Nursing homes and 2,00,000 Consultants. With 33 years of experience in delivering accurate reports, Metropolis has earned the reputation of being India's most respected and only multinational chain of diagnostic centres with presence in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana. Driven to make a difference, our wide network includes 125 state-of-art Laboratories across India with over 800 collection centres, processing over 4500 varieties of tests and supported by an efficient team of more than 3500 people. Equipped with cutting edge technology, innovative work equipment, expansive logistics network and rigorous processes, Metropolis ensures and delivers precision and accuracy in every single test; each time, every time.

In the last 10 years, Metropolis has expanded into new service lines like Clinical Trials, Hospital Lab Management, Home Health Services, Preventive Health Check-ups and Corporate & Wellness Solutions. Metropolis is at the forefront in adopting cutting edge technologies and services that contribute new revenue streams and has positioned the company on the pedestal it is today.

Today, we are one of the few laboratories that has received the CAP (College of American Pathologists), accreditation, the global gold standard in Laboratory Accreditation. 12 of our laboratories in India has received the NABL Accreditation (National Accreditation Board for testing and Calibration Laboratories). In addition, the central laboratory in Mumbai also adheres to CLIA (Clinical Laboratory Improvement Amendments) program and also follows the guidelines laid by GCP and GLP. Our unit in South Africa is accredited by SANAS (South African National Accreditation System is the only accreditation body approved by South African Government).

Metropolis has been awarded numerous accolades like the ‘Best Diagnostic Company of the year’ by Modern Medicare in 2006 and ‘Best Diagnostic Company of the Year’ in 2010 by Frost & Sullivan. Metropolis was also bestowed with ‘Best IT Integration in Customer Service Management’ at the e-Health World Expo 2011. Metropolis was also honoured with the ‘Quality Brand Award’ by NEHRDO in 2012. Metropolis won the ‘CMO Asia Award’ for Best IT practices in Healthcare in 2012. Metropolis Healthcare also bagged the Emerging Companies Excellence Award in the Productive Employment category hosted by Yes Bank and Business Today.

Metropolis Healthcare is led by Ameera Shah, Managing Director & CEO. An International & National Award winners, she was conferred with ‘The Young entrepreneur of the Year Award’ by GE in 2006 and ‘The Young Achiever of the Year Award’ at the CMO Asia Awards in 2011. She was also the recipient of the prestigious ‘Young Entrepreneur of the Year Award’ in 2011 organised by Entrepreneur India and Bloomberg. She has been honoured with ‘Women Leadership award’ at the World Women Leadership and Congress awards 2014. Recently she has been chosen as one of the most respected leaders under 40 years by Economic Times & Spencer Stuart (2014).

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Press Releases and tagged , , . Volume: .

Post a Comment

You must be logged in to post a comment.